Literature DB >> 10074013

Training in large bowel cancer surgery: observations from three prospective regional United Kingdom audits.

R J Aitken1, M R Thompson, J A Smith, A G Radcliffe, J D Stamatakis, R J Steele.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10074013      PMCID： PMC27780          DOI： 10.1136/bmj.318.7185.702

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival.

Authors:  C S McArdle; D Hole
Journal:  BMJ       Date:  1991-06-22
  1 in total
  7 in total

1.  Royal College of Surgeons of Edinburgh gives consultant fellows feedback on their training activity.

Authors:  D R Harper
Journal:  BMJ       Date:  1999-07-24

2.  Training in large bowel cancer surgery. Trainees' lack of operative experience is of even greater concern.

Authors:  W H Isbister
Journal:  BMJ       Date:  1999-07-31

3.  Surgical training, supervision, and service.

Authors:  C Collins
Journal:  BMJ       Date:  1999-03-13

4.  Surveillance of surgical training by detailed electronic registration of logical components.

Authors:  A Tøttrup
Journal:  Postgrad Med J       Date:  2002-10       Impact factor: 2.401

5.  Mentored Trainees have Similar Short-Term Outcomes to a Consultant Trainer Following Laparoscopic Colorectal Resection.

Authors:  Henry D De'Ath; Laurence Devoto; Chaitanya Mehta; James Bromilow; Tahseen Qureshi
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

Review 6.  The acute surgical unit model verses the traditional "on call" model: a systematic review and meta-analysis.

Authors:  Vinayak Nagaraja; Guy D Eslick; Michael R Cox
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

7.  The state of basic surgical training in the UK: ophthalmology as a case example.

Authors:  M P Watson; M G Boulton; A Gibson; P I Murray; M J Moseley; A R Fielder
Journal:  J R Soc Med       Date:  2004-04       Impact factor: 18.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.